BetterLife Provides Important Update on its Australian Clinical Study Design
Go back to BetterLife Provides Important Update on its Australian Clinical Study Design| (NASDAQ: BETR) | Delayed: 26.41 +2.31 (9.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.10 | 52 Week High | $17.53 | |||
| Open | $24.15 | 52 Week Low | $9.15 | |||
| Day High | $27.26 | P/E | N/A | |||
| Day Low | $24.06 | EPS | $0.00 | |||
| Volume | 146,846 | |||||
| (AMEX: BETRF) | Delayed: 0.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.05 | 52 Week High | $ | |||
| Open | $0.05 | 52 Week Low | $ | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.05 | EPS | $ | |||
| Volume | 458 | |||||
